GGrantIndex
← Leaderboards

Len Alexander Pennacchio

University Of Calif-Lawrenc Berkeley Lab

$35,353,607
Attributed
$46,942,370
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.3M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$46,942,370 · 9

By mechanism

R01$31,022,281 · 5
UM1$11,184,235 · 2
R24$3,892,946 · 1
R21$842,908 · 1

Top collaborators

Most similar at University Of Calif-Lawrenc Berkeley Lab

Same institution · by research overlap

Others in their field

Top investigators on “Tissues

Research focus

TissuesGenesGenomicsIn VivoEnhancersGene ExpressionReporterTransgenic MiceVariantHuman GenomeGenomeMapsCommunitiesTransgenic OrganismsResearch PersonnelMutationData SetBaseGenome SequencingLinkPhenotypeUntranslated RnaInsightResources

Grant awards (50)

Functionally Assessing Transcriptional Enhancers In Vivo$1,412,170
R01 · FY2025 · HG · contact PI
Evaluating the Impact of Mutations in Distant-Acting Enhancers in Structural Birth Defects$816,577
R01 · FY2025 · HD · contact PI
In vivo Characterization of Regulatory Variant Pathogenicity in Congenital Heart Disease$749,365
R01 · FY2025 · HL
Functionally Assessing Transcriptional Enhancers In Vivo$1,412,170
R01 · FY2024 · HG · contact PI
Evaluating the Impact of Mutations in Distant-Acting Enhancers in Structural Birth Defects$808,412
R01 · FY2024 · HD · contact PI
In vivo Characterization of Regulatory Variant Pathogenicity in Congenital Heart Disease$734,378
R01 · FY2024 · HL
Functionally Assessing Transcriptional Enhancers In Vivo$1,436,554
R01 · FY2023 · HG · contact PI
Evaluating the Impact of Mutations in Distant-Acting Enhancers in Structural Birth Defects$816,999
R01 · FY2023 · HD · contact PI
In vivo Characterization of Regulatory Variant Pathogenicity in Congenital Heart Disease$749,289
R01 · FY2023 · HL
Functionally Assessing Transcriptional Enhancers In Vivo$1,268,761
R01 · FY2022 · HG · contact PI
In vivo Characterization of Regulatory Variant Pathogenicity in Congenital Heart Disease$765,868
R01 · FY2022 · HL
In Vivo Characterization of Major ENCODE-Predicted Classes of Noncoding Elements$1,358,777
UM1 · FY2021 · HG · contact PI
Functionally Assessing Transcriptional Enhancers In Vivo$1,268,761
R01 · FY2021 · HG · contact PI
In Vivo Characterization of Major ENCODE-Predicted Classes of Noncoding Elements$1,348,257
UM1 · FY2020 · HG · contact PI
Functionally Assessing Transcriptional Enhancers In Vivo$1,268,761
R01 · FY2020 · HG · contact PI
In Vivo Characterization of Major ENCODE-Predicted Classes of Noncoding Elements$1,348,257
UM1 · FY2019 · HG · contact PI
Functionally Assessing Transcriptional Enhancers In Vivo$1,266,121
R01 · FY2019 · HG · contact PI
Regulation of Cardiac Development in Health and Disease$879,536
UM1 · FY2019 · HL
Genome-Wide Resources for Transcriptional Enhancers Active in the Human Heart$778,308
R24 · FY2019 · HL
In Vivo Characterization of Major ENCODE-Predicted Classes of Noncoding Elements$1,348,257
UM1 · FY2018 · HG · contact PI
Functionally Assessing Transcriptional Enhancers In Vivo$1,286,578
R01 · FY2018 · HG · contact PI
Regulation of Cardiac Development in Health and Disease$879,536
UM1 · FY2018 · HL
Genome-Wide Resources for Transcriptional Enhancers Active in the Human Heart$778,308
R24 · FY2018 · HL
In Vivo Characterization of Major ENCODE-Predicted Classes of Noncoding Elements$1,348,257
UM1 · FY2017 · HG · contact PI
Functionally Assessing Transcriptional Enhancers In Vivo$1,136,834
R01 · FY2017 · HG · contact PI
Regulation of Cardiac Development in Health and Disease$879,536
UM1 · FY2017 · HL
Genome-Wide Resources for Transcriptional Enhancers Active in the Human Heart$778,308
R24 · FY2017 · HL
Functionally Assessing Transcriptional Enhancers In Vivo$1,136,834
R01 · FY2016 · HG · contact PI
Regulation of Cardiac Development in Health and Disease$879,536
UM1 · FY2016 · HL
Genome-Wide Resources for Transcriptional Enhancers Active in the Human Heart$779,011
R24 · FY2016 · HL
Functionally Assessing Transcriptional Enhancers In Vivo$1,108,412
R01 · FY2015 · HG · contact PI
Regulation of Cardiac Development in Health and Disease$914,286
UM1 · FY2015 · HL
Genome-Wide Resources for Transcriptional Enhancers Active in the Human Heart$779,011
R24 · FY2015 · HL
Functionally Assessing Transcriptional Enhancers In Vivo$1,136,834
R01 · FY2014 · HG · contact PI
Generation of an In Vivo Human Genome Enhancer Dataset$1,082,698
R01 · FY2013 · HG · contact PI
Generation of an In Vivo Human Genome Enhancer Dataset$1,133,716
R01 · FY2012 · HG · contact PI
Generation of an In Vivo Human Genome Enhancer Dataset$1,122,379
R01 · FY2011 · HG · contact PI
Generation of an In Vivo Human Genome Enhancer Dataset$1,154,852
R01 · FY2010 · HG · contact PI
A High-Resolution Enhancer Atlas of the Developing Forebrain$566,994
R01 · FY2010 · NS · contact PI
In Vivo Analysis of a Noncoding Susceptibility Region for Coronary Artery Disease$421,454
R21 · FY2010 · HL · contact PI
Generation of an In Vivo Human Genome Transcriptional Enhancer Dataset$704,936
R01 · FY2009 · HG · contact PI
A High-Resolution Enhancer Atlas of the Developing Forebrain$551,079
R01 · FY2009 · NS · contact PI
In Vivo Analysis of a Noncoding Susceptibility Region for Coronary Artery Disease$421,454
R21 · FY2009 · HL · contact PI
Generation of an In Vivo Human Genome Transcriptional Enhancer Dataset$352,224
R01 · FY2009 · HG · contact PI
Generation of an In Vivo Human Genome Transcriptional Enhancer Dataset$678,213
R01 · FY2008 · HG · contact PI
A High-Resolution Enhancer Atlas of the Developing Forebrain$549,631
R01 · FY2008 · NS · contact PI
Generation of an In Vivo Human Genome Transcriptional Enhancer Dataset$668,808
R01 · FY2007 · HG · contact PI
Generation of an In Vivo Human Genome Transcriptional Enhancer Dataset$688,102
R01 · FY2006 · HG · contact PI
Genetic and Genomic Analysis of apoAV$596,628
R01 · FY2006 · HL · contact PI
Genetic and Genomic Analysis of apoAV$592,343
R01 · FY2005 · HL